Currently Javascript deactivated in your browser.
Search

Kovai Medical

By Sunidhi Securities 

Sunday, February 17, 2013
     

Sunidhi Securities is bullish on Kovai Medical Center and Hospital (KMCH) and has recommended buy rating on the stock with a target price of 225 in its February 15, 2013 research report.

Kovai Medical reported a healthy growth during the Q3 financial year 2013 as the sales increased by 37.9 percent to 79.3 crore and net profit by 108.8 percent to 7.1 crore. Instead of 30 percent higher depreciation of 3.9 crore, 192 percent higher tax provision of 3.8 crore and 48.9 percent and increased burden of interest cost at 7.0 crore, the hospital managed to achieve the increased net. The KMCH is leading among the services provided as the hospital expertise collaborated with the state of the art equipments. Kovai Medical Center and Hospital (KMCH) is an India-based company engaged in the running of hospitals. The Company is a 657-bed multi-disciplinary, super-specialty hospital located in Coimbatore, India. The hospital has more than 50 medical disciplines and is equipped with 20 operation theatres. Super specialty procedures, such as open heart surgeries, valve replacements, kidney transplants, hip and knee replacements, brain surgeries and spine surgeries are performed at the hospital.

At present Kovai Medical is being traded at 164.00. Its 52 week high is 195.00 and 52 week low has been 91.00.